Molecular modelling of the vasopressin V2 receptor/antagonist interactions

Acta Biochimica Polonica

Volumn 45, Issue 1, 1998, Pages 19-26

  Czaplewski, Cezary ^a   Kaźmierkiewicz, Rajmund ^a   Ciarkowski, Jerzy ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

AMBER 4.1; GPCR receptor bioligand interactions; Molecular dynamics; Simulated annealing

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN, BETA MERCAPTO(BETA,BETA) CYCLOPENTAMETHYLENEPROPIONIC ACID(1) ILE(2,4) ALA NH2(9); ARGIPRESSIN, BETA MERCAPTO(BETA,BETA)-CYCLOPENTAMETHYLENEPROPIONIC ACID(1)-ILE(2,4)-ALA-NH2(9)-; BENZAZEPINE DERIVATIVE; DRUG DERIVATIVE; MOZAVAPTAN; VASOPRESSIN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ARGININE VASOPRESSIN; BENZAZEPINES; KIDNEY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, VASOPRESSIN;

EID: 0031604822     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1998_4314     Document Type: Article

References (19)

1. Schertler, G.F.X. & Hargrave, P.A. (1995) Projection structure of frog rhodopsin in two crystal forms. Proc. Natl. Acad. Sci. U.S.A. 92, 11578-11582.
2. Baldwin, J.M. (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12, 1693-1703.
3. Herzyk, P. & Hubbard, R.E. (1995) Automated method for modeling seven-helix transmembrane receptors from experimental data. Biophys. J. 69, 2419-2442.
4. Peitsch, M.C., Herzyk, P., Wells, T.N.C. & Hubbard, R. (1995) Automated G protein-coupled receptor modeling by Swiss-Model: URL http://expasy.hcuge.ch/swissmod/SWI-SS-MODEL.html.
5. Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S. & Kawashima, H. (1994) Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J. Biol. Chem. 269, 27088-27092.
6. De Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X. & Clauser, E. (1994) Cloning and characterisation of the human V3 pituitary vasopressin receptor. FEBS Lett. 356, 215-220.
7. Iismaa, T.P., Biden, T.J. & Shine, J. (1995) G Protein-Coupled Receptors, Chapter 1, Springer-Verlag, Heidelberg.
8. Manning, M. & Sawyer, W.H. (1993) Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J. Recept. Res. 13, 195-214.
9. Yamamura, Y., Ogawa, H., Yamashita, H., Chihara, T., Miyamoto, H., Nakamura, S., Onogawa, T., Yamashita, T., Hosokawa, T., Mori, T., Tominaga, M. & Yabuuchi, Y. (1992) Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br. J. Pharmacol. 105, 787-791.
10. Czaplewski, C., Kaźmierkiewicz, R. & Ciarkowski, J. (1998) Molecular modeling of the human vasopressin V2 receptor/agonist complex. J. Comp.-Aided Molec. Design 12, in press.
11. Barberis, C. & Tribollet, E. (1996) Vasopressin and oxytocin receptors in the central nervous system. Crit. Rev. Neurobiol. 10, 119-154.
12. Baldwin, J.M. (1994) Structure and function of receptors coupled to G proteins. Curr. Opin. Cell. Biol. 6, 180-190.
13. SYBYL, v. 6.1 (1994) Tripos Inc., St. Louis, MO, U.S.A.
14. AMBER, v. 4.1 (1995) Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham III, T.E., Ferguson, D.M., Seibel, G.L., Singh, U.C., Weiner, P.K. & Kollman, P.A., University of California, San Francisco, CA, U.S.A.
15. Schmidt, M.W., Baldridge, K.K., Boatz, J.A., Elbert, S.T., Gordon, M.S., Jensen, J.H., Koseki, S., Matsunaga, N., Nguyen, K.A., Su, S., Windus, T.L., Dupuis, M. & Montgomery, J.A. (1993) General atomic and molekular electronic structure system. J. Comput. Chem. 14, 1347-1363.
16. Bayly, C.I., Cieplak, P., Cornell, W.D. & Kollman, P. (1993) A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J. Phys. Chem. 97, 10269-10280.
17. Koradi, R., Billeter, M. & Wüthrich, K. (1996) MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graphics 14, 51-55.
18. 2 receptor antagonists: A novel series of 1-[4-(benzoyl-amino)benzoyl]-2,3,4,5-tetrahydro-1H-benza-zepines and related compounds. J. Med Chem 39, 3547-3555.
19. Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack J., Hibert, M, Jard,S. & Barberis, C. (1995) The binding site of neuropeptide vasopressin V1a receptor. J. Biol. Chem. 270, 25771-25777.